Regan Daniel Paul
Insider CIK 1571320 · KERX Director · ICPT Chief Commerical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KERX KERYX BIOPHARMACEUTICALS I | D To issuer deriv | 2018-12-12 | 2018-12-13 | 200,000 | — | $0 | 0 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | D To issuer | 2018-12-12 | 2018-12-13 | 60,000 | — | $0 | 0 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2018-06-30 | 2018-07-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2018-06-30 | 2018-07-12 | 10,000 | — | $0 | 60,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2017-06-09 | 2017-06-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2017-06-09 | 2017-06-20 | 10,000 | — | $0 | 50,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2016-05-26 | 2016-05-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2016-05-26 | 2016-05-27 | 10,000 | — | $0 | 40,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2015-06-17 | 2015-06-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2015-06-17 | 2015-06-18 | 10,000 | — | $0 | 30,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-01-30 | 2015-02-03 | 9,847 | — | $0 | 92,028 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-01-30 | 2015-02-03 | 9,847 | $37.69 | $371.1K | 11,111 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-01-30 | 2015-02-03 | 6,847 | $200.07 | $1.37M | 4,264 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-01-30 | 2015-02-03 | 793 | $202.49 | $160.6K | 2,264 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-01-30 | 2015-02-03 | 1,207 | $201.50 | $243.2K | 3,057 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-01-30 | 2015-02-03 | 800 | $205.87 | $164.7K | 1,464 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-01-30 | 2015-02-03 | 200 | $208.08 | $41.6K | 1,264 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2015-01-05 | 2015-01-07 | 146 | $176.49 | $25.8K | 1,264 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-08-12 | 2014-08-15 | 8,124 | — | $0 | 101,875 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 200 | $321.44 | $64.3K | 5,434 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 100 | $322.92 | $32.3K | 5,334 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 100 | $326.03 | $32.6K | 5,234 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 300 | $327.89 | $98.4K | 4,934 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 594 | $329.59 | $195.8K | 4,340 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 206 | $330.91 | $68.2K | 4,134 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 200 | $331.92 | $66.4K | 3,934 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 100 | $335.02 | $33.5K | 3,834 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 200 | $336.47 | $67.3K | 3,634 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 100 | $337.17 | $33.7K | 3,534 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 224 | $346.68 | $77.7K | 1,410 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 300 | $342.05 | $102.6K | 2,934 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 800 | $343.80 | $275.0K | 2,134 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-08-12 | 2014-08-15 | 8,124 | $37.69 | $306.2K | 9,534 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 200 | $305.39 | $61.1K | 9,334 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 100 | $306.91 | $30.7K | 9,234 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 500 | $310.10 | $155.1K | 8,734 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 500 | $311.89 | $155.9K | 8,234 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 200 | $312.78 | $62.6K | 8,034 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 800 | $313.84 | $251.1K | 7,234 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 600 | $314.93 | $189.0K | 6,634 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 200 | $316.62 | $63.3K | 6,434 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 400 | $317.71 | $127.1K | 6,034 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 400 | $319.47 | $127.8K | 5,634 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 500 | $344.73 | $172.4K | 1,634 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-08-12 | 2014-08-15 | 300 | $341.21 | $102.4K | 3,234 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-07-03 | 2014-07-08 | 1 | — | $0 | 109,999 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-07-03 | 2014-07-08 | 1 | $250.00 | $250 | 1,410 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-07-03 | 2014-07-08 | 1 | $37.69 | $38 | 1,411 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2014-06-24 | 2014-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2014-06-24 | 2014-06-26 | 10,000 | — | $0 | 20,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2014-04-11 | 2014-04-15 | 1,720 | — | $0 | 1,720 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2014-04-11 | 2014-04-15 | 6,421 | — | $0 | 6,421 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2014-04-11 | 2014-04-15 | 1,410 | — | $0 | 1,410 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2014-03-05 | 2014-03-07 | 20,000 | — | $0 | 110,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-03-05 | 2014-03-07 | 361 | $429.95 | $155.2K | 17,939 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-03-05 | 2014-03-07 | 7,027 | $433.47 | $3.05M | 8,849 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-03-05 | 2014-03-07 | 1,949 | $434.57 | $847.0K | 6,900 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-03-05 | 2014-03-07 | 1,140 | $435.70 | $496.7K | 5,760 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-03-05 | 2014-03-07 | 1,960 | $436.77 | $856.1K | 3,800 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-03-05 | 2014-03-07 | 898 | $438.45 | $393.7K | 2,902 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-03-05 | 2014-03-07 | 502 | $439.94 | $220.8K | 2,400 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-03-05 | 2014-03-07 | 812 | $440.63 | $357.8K | 1,588 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-03-05 | 2014-03-07 | 1,288 | $441.59 | $568.8K | 300 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-03-05 | 2014-03-07 | 300 | $442.49 | $132.7K | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2014-03-05 | 2014-03-07 | 20,000 | $37.69 | $753.8K | 20,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-03-05 | 2014-03-07 | 500 | $426.06 | $213.0K | 19,500 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-03-05 | 2014-03-07 | 500 | $427.05 | $213.5K | 19,000 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-03-05 | 2014-03-07 | 700 | $428.51 | $300.0K | 18,300 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-03-05 | 2014-03-07 | 1,724 | $432.84 | $746.2K | 15,876 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | S Sale | 2014-03-05 | 2014-03-07 | 339 | $431.34 | $146.2K | 17,600 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2013-03-04 | 2013-03-06 | 130,000 | — | $0 | 130,000 | SEC↗ |